{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T09:49:46Z","timestamp":1756460986531},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.advms.2016.06.004","type":"journal-article","created":{"date-parts":[[2017,1,30]],"date-time":"2017-01-30T21:48:10Z","timestamp":1485812890000},"page":"31-38","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Amyloidosis: A cancer-derived paraproteinemia and kidney involvement"],"prefix":"10.1016","volume":"62","author":[{"given":"Jolanta","family":"Ma\u0142yszko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaudia","family":"Koz\u0142owska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek Stanis\u0142aw","family":"Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0350","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1046\/j.1365-2141.2001.02999.x","article-title":"Amyloidosis: a convoluted story","volume":"114","author":"Kyle","year":"2001","journal-title":"Br J Haematol"},{"issue":"4669","key":"10.1016\/j.advms.2016.06.004_bib0355","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/1831202a0","article-title":"Electron microscopic observations on a fibrous component in amyloid of diverse origins","volume":"183","author":"Cohen","year":"1959","journal-title":"Nature"},{"issue":"3\u20134","key":"10.1016\/j.advms.2016.06.004_bib0360","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/jemt.20190","article-title":"Structure and morphology of the Alzheimer's amyloid fibril","volume":"67","author":"Stromer","year":"2005","journal-title":"Microsc Res Tech"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0365","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2174\/092986606775338498","article-title":"Amyloid under the atomic force microscope","volume":"13","author":"Gosal","year":"2006","journal-title":"Protein Pept Lett"},{"issue":"Suppl 1","key":"10.1016\/j.advms.2016.06.004_bib0370","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3109\/13506129.2011.574354017","article-title":"Amyloid detection and typing: summary of current practice and recommendations of the consensus group","volume":"18","author":"Picken","year":"2011","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0375","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1182\/blood-2011-06-358507","article-title":"Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients","volume":"119","author":"Sch\u00f6nland","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0380","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chembiol.2012.02.003","article-title":"Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships","volume":"19","author":"Bemporad","year":"2012","journal-title":"Chem Biol"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0385","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3109\/13506129.2014.964858","article-title":"Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis","volume":"21","author":"Sipe","year":"2014","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.advms.2016.06.004_bib0390","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1586\/17474086.2014.858594","article-title":"Immunoglobulin light chain amyloidosis","volume":"7","author":"Merlini","year":"2014","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.advms.2016.06.004_bib0395","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/978-94-007-5416-4_20","article-title":"Systemic AA amyloidosis","volume":"65","author":"Pinney","year":"2012","journal-title":"Subcell Biochem"},{"issue":"1","key":"10.1016\/j.advms.2016.06.004_bib0400","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/hdi.12057","article-title":"Impact of advanced dialysis technology on the prevalence of dialysis-related amyloidosis in long-term maintenance dialysis patients","volume":"18","author":"Schiffl","year":"2014","journal-title":"Hemodial Int"},{"issue":"6","key":"10.1016\/j.advms.2016.06.004_bib0405","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0410","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ki.2008.152","article-title":"Leukocyte chemotactic factor 2: a novel renal amyloid protein","volume":"74","author":"Benson","year":"2008","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0415","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00005792-199107000-00002","article-title":"Secondary systemic amyloidosis: response and survival in 64 patients","volume":"70","author":"Gertz","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0420","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/j.1523-1755.2004.00485.x","article-title":"Renal amyloidosis in familial Mediterranean fever","volume":"65","author":"Ozen","year":"2004","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.advms.2016.06.004_bib0425","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/qjmed\/hcl092","article-title":"Renal amyloidosis in intravenous drug users","volume":"99","author":"Connolly","year":"2006","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0430","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","article-title":"Hereditary periodic fever and reactive amyloidosis","volume":"5","author":"van der Hilst","year":"2005","journal-title":"Clin Exp Med"},{"issue":"1","key":"10.1016\/j.advms.2016.06.004_bib0435","doi-asserted-by":"publisher","first-page":"R86","DOI":"10.1152\/ajpregu.00504.2006","article-title":"Pathogenesis of familial periodic fever syndromes or hereditary autoinflammatory syndromes","volume":"292","author":"Simon","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"18","key":"10.1016\/j.advms.2016.06.004_bib0440","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0445","doi-asserted-by":"publisher","first-page":"e002877","DOI":"10.1161\/JAHA.115.002877","article-title":"Subtype-specific interactions and prognosis in cardiac amyloidosis","volume":"4","author":"Sperry","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0450","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol"},{"issue":"14","key":"10.1016\/j.advms.2016.06.004_bib0455","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","article-title":"Amyloidosis: pathogenesis and new therapeutic options","volume":"29","author":"Merlini","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.advms.2016.06.004_bib0460","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/nrneph.2013.171","article-title":"Pathophysiology and treatment of systemic amyloidosis","volume":"9","author":"Gillmore","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0465","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5414\/CN107151","article-title":"AA amyloid nephropathy with predominant vascular deposition in Crohn's disease","volume":"79","author":"Kurita","year":"2013","journal-title":"Clin Nephrol"},{"issue":"9","key":"10.1016\/j.advms.2016.06.004_bib0470","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2215\/CJN.10491012","article-title":"Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases","volume":"8","author":"Said","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"10.1016\/j.advms.2016.06.004_bib0475","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1182\/blood-2010-06-290668","article-title":"Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features","volume":"116","author":"Kumar","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.advms.2016.06.004_bib0480","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/14737159.2014.864557","article-title":"Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions","volume":"14","author":"Graziani","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0485","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5858\/134.4.545","article-title":"Amyloidosis\u2014where are we now and where are we heading?","volume":"134","author":"Picken","year":"2010","journal-title":"Arch Path Lab Med"},{"issue":"6","key":"10.1016\/j.advms.2016.06.004_bib0490","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ckj\/sfv087","article-title":"Proteomics and mass spectrometry in the diagnosis of renal amyloidosis","volume":"8","author":"Picken","year":"2015","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0495","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1136\/jclinpath-2014-202722","article-title":"A comparison of immunohistochemistry and mass spectrometry for determining the amyloid fibril protein from formalin-fixed biopsy tissue","volume":"68","author":"Gilbertson","year":"2015","journal-title":"J Clin Pathol"},{"issue":"23","key":"10.1016\/j.advms.2016.06.004_bib0500","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMoa013354","article-title":"Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis","volume":"346","author":"Lachmann","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0505","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ki.2014.45","article-title":"Alect2 amyloidosis: primum non nocere (first, do no harm)","volume":"86","author":"Picken","year":"2014","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0510","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/ki.2014.368","article-title":"Emerging treatments for amyloidosis","volume":"87","author":"Sayed","year":"2015","journal-title":"Kidney Int"},{"issue":"23","key":"10.1016\/j.advms.2016.06.004_bib0515","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1056\/NEJM198006053022305","article-title":"Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts)","volume":"302","author":"Glenner","year":"1980","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.advms.2016.06.004_bib0520","first-page":"1482","article-title":"Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis","volume":"33","author":"Uda","year":"2006","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0525","first-page":"137","article-title":"Predominantly vascular amyloid deposition in the kidney in patients with minimal or no proteinuria","volume":"19","author":"Falck","year":"1983","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0530","first-page":"377","article-title":"AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product","volume":"137","author":"Westermark","year":"1990","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0535","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0002-9343(86)90550-4","article-title":"Amyloidosis in subcutaneous heroin abusers (\u201cskin poppers\u2019 amyloidosis\u201d)","volume":"81","author":"Neugarten","year":"1986","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0540","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000168336","article-title":"Fanconi's syndrome, kappa light-chain myeloma, non-amyloid fibrils and cytoplasmic crystals in renal tubular epithelium","volume":"11","author":"Orfila","year":"1991","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.advms.2016.06.004_bib0545","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0272-6386(96)90250-4","article-title":"Extracapillary glomerulonephritis and renal amyloidosis","volume":"28","author":"Moroni","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.advms.2016.06.004_bib0550","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1681\/ASN.2015020185","article-title":"Light chain proximal tubulopathy: clinical and pathologic characteristics in the modern treatment era","volume":"27","author":"Stokes","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0555","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1172\/JCI117027","article-title":"Hereditary renal amyloidosis with a novel variant fibrinogen","volume":"93","author":"Uemichi","year":"1994","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0560","first-page":"149","article-title":"Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26","volume":"87","author":"Vigushin","year":"1994","journal-title":"Q J Med"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0565","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1046\/j.1523-1755.2002.00205.x","article-title":"Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family","volume":"61","author":"Valleix","year":"2002","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.advms.2016.06.004_bib0570","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1046\/j.1523-1755.2003.00904.x","article-title":"A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis","volume":"63","author":"Yazaki","year":"2003","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.advms.2016.06.004_bib0575","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1681\/ASN.2008070813","article-title":"Nephrotic syndrome due to an amyloidogenic mutation in fibrinogen A alpha chain","volume":"20","author":"Picken","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.advms.2016.06.004_bib0580","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0585","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/ki.2013.558","article-title":"Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis","volume":"86","author":"Said","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0590","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/modpathol.2016.29","article-title":"Leukocyte chemotactic factor 2 amyloidosis (ALECT2) is a common form of renal amyloidosis among Egyptians","volume":"29","author":"Larsen","year":"2016","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.advms.2016.06.004_bib0595","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/00007890-198612000-00005","article-title":"Renal transplantation in 45 patients with amyloidosis","volume":"42","author":"Pasternack","year":"1986","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.advms.2016.06.004_bib0600","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/ndt\/9.6.704","article-title":"Study of live donor kidney transplantation outcome in recipients with renal amyloidosis","volume":"9","author":"Sobh","year":"1994","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0605","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0272-6386(03)00676-0","article-title":"Long-term outcome of live donor kidney transplantation for renal amyloidosis","volume":"42","author":"Sherif","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.advms.2016.06.004_bib0610","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0615","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1681\/ASN.2008060614","article-title":"Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis","volume":"20","author":"Gillmore","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0620","doi-asserted-by":"publisher","first-page":"440","DOI":"10.2215\/CJN.02450706","article-title":"Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation","volume":"2","author":"Leung","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0625","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","article-title":"High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study","volume":"140","author":"Skinner","year":"2004","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.advms.2016.06.004_bib0630","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/1078-0432.CCR-10-1950","article-title":"Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events","volume":"17","author":"Arastu-Kapur","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.advms.2016.06.004_bib0635","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2215\/CJN.08640811","article-title":"Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution","volume":"7","author":"Nasr","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.advms.2016.06.004_bib0640","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1681\/ASN.2009010110","article-title":"Proliferative glomerulonephritis with monoclonal IgG deposits","volume":"20","author":"Nasr","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.advms.2016.06.004_bib0645","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0272-6386(03)00412-8","article-title":"Monoclonal gammopathy: significance and possible causality in renal disease","volume":"42","author":"Paueksakon","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.advms.2016.06.004_bib0650","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.2215\/CJN.12231212","article-title":"Kidney disease and multiple myeloma","volume":"8","author":"Heher","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.advms.2016.06.004_bib0655","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/0002-9343(76)90580-5","article-title":"Malignant lymphoma with \u201cmyeloma kidney\u201d acute renal failure","volume":"60","author":"Burke","year":"1976","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0660","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1159\/000064299","article-title":"Cast nephropathy in a case of Waldenstr\u00f6m's macroglobulinemia","volume":"91","author":"Isaac","year":"2002","journal-title":"Nephron"},{"issue":"30","key":"10.1016\/j.advms.2016.06.004_bib0665","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1200\/JCO.2010.28.1238","article-title":"Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II study","volume":"28","author":"Ludwig","year":"2010","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.advms.2016.06.004_bib0670","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1200\/JCO.2011.39.6820","article-title":"Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65\/GMMG-HD4 trial","volume":"30","author":"Sonneveld","year":"2012","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.advms.2016.06.004_bib0675","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1172\/JCI46490","article-title":"Mechanism and prevention of acute kidney injury from cast nephropathy in a rodent model","volume":"122","author":"Ying","year":"2012","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.advms.2016.06.004_bib0680","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/0003-4819-143-11-200512060-00005","article-title":"Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial","volume":"143","author":"Clark","year":"2005","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.advms.2016.06.004_bib0685","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1537-2995.2006.01143.x","article-title":"Light-chain removal by plasmapheresis in myeloma-associated renal failure","volume":"47","author":"Cserti","year":"2007","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.advms.2016.06.004_bib0690","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2215\/CJN.04590908","article-title":"Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis","volume":"4","author":"Hutchison","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112616300359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112616300359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T01:49:10Z","timestamp":1658540950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112616300359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1896112616300359"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2016.06.004","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidosis: A cancer-derived paraproteinemia and kidney involvement","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2016.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Medical University of Bialystok. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}